Given its significant role in cancer metabolism, PKM2 has been investigated as a potential biomarker for cancer. Elevated levels of PKM2 have been found in various tumor types and in the blood of cancer patients. This makes it a promising candidate for non-invasive diagnostic tests. However, further research is needed to fully establish its efficacy and specificity as a cancer marker.
